JP Patent

JP6758677B2 — グルタルイミド誘導体を含む医薬組成物、及び好酸球性疾患を処置するためのその適用

Assigned to オブシェストヴォ・ス・オグラニチェンノイ・オトヴェトストヴェンノストジュ・“ファームエンタープライジーズ” · Expires 2020-09-23 · 6y expired

What this patent protects

Patent listed against pimavanserin-tartrate.

Drugs covered by this patent

Patent Metadata

Patent number
JP6758677B2
Jurisdiction
JP
Classification
—
Expires
2020-09-23
Drug substance claim
No
Drug product claim
No
Assignee
オブシェストヴォ・ス・オグラニチェンノイ・オトヴェトストヴェンノストジュ・“ファームエンタープライジーズ”
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.